Natus Medical Incorporated Stock Net Income
| NM4 Stock | EUR 0.27 0.01 3.57% |
As of the 3rd of February, Natus Medical secures the Mean Deviation of 3.71, risk adjusted performance of (0.13), and Standard Deviation of 4.74. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Natus Medical, as well as the relationship between them. Please verify Natus Medical coefficient of variation, variance, and the relationship between the mean deviation and standard deviation to decide if Natus Medical Incorporated is priced some-what accurately, providing market reflects its recent price of 0.27 per share.
Natus Medical Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization 13 M | Enterprise Value Revenue 0.7814 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -76.3 M | -72.5 M | |
| Net Income Applicable To Common Shares | 11.9 M | 12.5 M | |
| Net Loss | -69.2 M | -65.8 M |
Natus | Net Income |
The Net Income trend for Natus Medical Incorporated offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Natus Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Natus Medical's Net Income Growth Pattern
Below is the plot of the Net Income of Natus Medical Incorporated over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Natus Medical financial statement analysis. It represents the amount of money remaining after all of Natus Medical Incorporated operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Natus Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Natus Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (76.94 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Natus Net Income Regression Statistics
| Arithmetic Mean | (4,110,615) | |
| Coefficient Of Variation | (982.63) | |
| Mean Deviation | 33,996,461 | |
| Median | (4,259,000) | |
| Standard Deviation | 40,392,061 | |
| Sample Variance | 1631.5T | |
| Range | 119.5M | |
| R-Value | (0.86) | |
| Mean Square Error | 465.4T | |
| R-Squared | 0.73 | |
| Significance | 0.000012 | |
| Slope | (6,846,095) | |
| Total Sum of Squares | 26104.3T |
Natus Net Income History
Natus Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Natus Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Natus Medical.
| 11/05/2025 |
| 02/03/2026 |
If you would invest 0.00 in Natus Medical on November 5, 2025 and sell it all today you would earn a total of 0.00 from holding Natus Medical Incorporated or generate 0.0% return on investment in Natus Medical over 90 days. Natus Medical is related to or competes with Genmab A/S, Tokentus Investment, Green Plains, Vishay Intertechnology, Dave Busters, Shin Etsu, and Lattice Semiconductor. Natus Medical Incorporated provides neurology, newborn care, and hearing and balance assessment healthcare products and ... More
Natus Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Natus Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Natus Medical Incorporated upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.20) | |||
| Maximum Drawdown | 25.32 | |||
| Value At Risk | (8.57) | |||
| Potential Upside | 5.88 |
Natus Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Natus Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Natus Medical's standard deviation. In reality, there are many statistical measures that can use Natus Medical historical prices to predict the future Natus Medical's volatility.| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (0.92) | |||
| Total Risk Alpha | (1.18) | |||
| Treynor Ratio | (1.16) |
Natus Medical February 3, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.13) | |||
| Market Risk Adjusted Performance | (1.15) | |||
| Mean Deviation | 3.71 | |||
| Coefficient Of Variation | (540.75) | |||
| Standard Deviation | 4.74 | |||
| Variance | 22.43 | |||
| Information Ratio | (0.20) | |||
| Jensen Alpha | (0.92) | |||
| Total Risk Alpha | (1.18) | |||
| Treynor Ratio | (1.16) | |||
| Maximum Drawdown | 25.32 | |||
| Value At Risk | (8.57) | |||
| Potential Upside | 5.88 | |||
| Skewness | (0.14) | |||
| Kurtosis | 0.3711 |
Natus Medical Backtested Returns
Natus Medical has Sharpe Ratio of -0.17, which conveys that the firm had a -0.17 % return per unit of risk over the last 3 months. Natus Medical exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Natus Medical's Mean Deviation of 3.71, standard deviation of 4.74, and Risk Adjusted Performance of (0.13) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.77, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Natus Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Natus Medical is expected to be smaller as well. At this point, Natus Medical has a negative expected return of -0.82%. Please make sure to verify Natus Medical's value at risk, skewness, accumulation distribution, as well as the relationship between the potential upside and kurtosis , to decide if Natus Medical performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.56 |
Modest predictability
Natus Medical Incorporated has modest predictability. Overlapping area represents the amount of predictability between Natus Medical time series from 5th of November 2025 to 20th of December 2025 and 20th of December 2025 to 3rd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Natus Medical price movement. The serial correlation of 0.56 indicates that roughly 56.0% of current Natus Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.56 | |
| Spearman Rank Test | 0.13 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Natus Operating Income
Operating Income |
|
Based on the recorded statements, Natus Medical Incorporated reported net income of (76.94 Million). This is 122.54% lower than that of the Oil, Gas & Consumable Fuels sector and 132.31% lower than that of the Energy industry. The net income for all Germany stocks is 113.48% higher than that of the company.
Natus Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Natus Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Natus Medical could also be used in its relative valuation, which is a method of valuing Natus Medical by comparing valuation metrics of similar companies.Natus Medical is currently under evaluation in net income category among its peers.
Natus Fundamentals
| Return On Equity | -3.24 | ||||
| Return On Asset | -0.18 | ||||
| Profit Margin | (0.29) % | ||||
| Current Valuation | 23.11 M | ||||
| Shares Outstanding | 47.56 M | ||||
| Shares Owned By Insiders | 46.03 % | ||||
| Price To Earning | 57.12 X | ||||
| Price To Book | 2.78 X | ||||
| Price To Sales | 0.25 X | ||||
| Revenue | 323.56 M | ||||
| Gross Profit | 279.92 M | ||||
| EBITDA | (26.72 M) | ||||
| Net Income | (76.94 M) | ||||
| Cash And Equivalents | 53.42 M | ||||
| Cash Per Share | 1.59 X | ||||
| Total Debt | 34.26 M | ||||
| Debt To Equity | 33.30 % | ||||
| Current Ratio | 1.70 X | ||||
| Book Value Per Share | (0.27) X | ||||
| Cash Flow From Operations | 1.47 M | ||||
| Earnings Per Share | (0.38) X | ||||
| Number Of Employees | 193 | ||||
| Beta | -0.78 | ||||
| Market Capitalization | 13.03 M | ||||
| Total Asset | 263.55 M | ||||
| Working Capital | (63.31 M) | ||||
| Net Asset | 263.55 M |
About Natus Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Natus Medical Incorporated's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Natus Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Natus Medical Incorporated based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Natus Stock
Natus Medical financial ratios help investors to determine whether Natus Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Natus with respect to the benefits of owning Natus Medical security.